Chuanzhong Huang
Overview
Explore the profile of Chuanzhong Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deng Y, Chen X, Chen X, Huang C, Zhang Z, Xu Z, et al.
BMC Cancer
. 2024 Sep;
24(1):1158.
PMID: 39289660
Background: Post-translational modification pathway of protein ubiquitination is intricately associated with tumorigenesis. We previously reported elevated ubiquitin-conjugating enzyme 2T (UBE2T) as an independent risk factor in stage I lung adenocarcinoma...
2.
Wang L, Huang C, Lin W, Zhou Z, Li J, Chen M, et al.
Ann Hepatol
. 2024 Sep;
30(1):101564.
PMID: 39276983
Introduction And Objectives: To study the effect of eukaryotic initiation factor 3B (EIF3B) on the invasion and migration of hepatocellular carcinoma (HCC) and its potential mechanism. Materials And Methods: The...
3.
Hong Y, Chen Q, Wang Z, Zhang Y, Li B, Guo H, et al.
Adv Sci (Weinh)
. 2024 Jul;
11(33):e2310037.
PMID: 38953362
Programmed death-ligand 1 (PD-L1) is overexpressed in multiple cancers and critical for their immune escape. It has previously shown that the nuclear coactivator SRC-1 promoted colorectal cancer (CRC) progression by...
4.
Huang W, Wang C, Shen Y, Chen Q, Huang Z, Liu J, et al.
BMC Cancer
. 2024 Mar;
24(1):378.
PMID: 38528446
No abstract available.
5.
Huang W, Wang C, Wang L, Shen Y, Chen Q, Huang Z, et al.
Front Cell Dev Biol
. 2024 Mar;
12:1313610.
PMID: 38481526
Patients with Triple-negative breast cancer (TNBC) face a poor prognosis and limited therapeutic options. Current data on eribulin usage to treat TNBC is scarce. Therefore, we sought to compare the...
6.
Huang C, Ding J, Huang C, Yu L, Chitapanarux I, Mejia M, et al.
Transl Cancer Res
. 2024 Jan;
12(12):3718-3727.
PMID: 38192995
Background: Circulating immune cells are associated with tumor development and poor prognosis in multiple solid tumors. However, the circulating immune-cell profile of nasopharyngeal carcinoma (NPC) remains largely unknown. Therefore, we...
7.
Huang W, Wang C, Shen Y, Chen Q, Huang Z, Liu J, et al.
BMC Cancer
. 2024 Jan;
24(1):39.
PMID: 38182995
Purpose: This investigation sought to examine the efficacy and safety of low-dose apatinib used alongside chemotherapy in the clinical management of patients with metastatic triple-negative breast cancer (TNBC) within a...
8.
Huang C, Wang L, Chen H, Fu W, Shao L, Zhou D, et al.
BMC Cancer
. 2023 May;
23(1):429.
PMID: 37170184
Objective: To study the effect of inhibitor of differentiation 3 (ID3) on radiotherapy in patients with rectal cancer and to explore its primary mechanism. Methods: Cell proliferation and clonogenic assays...
9.
Zhuang Z, Pan X, Zhang M, Liu Y, Huang C, Li Y, et al.
Virulence
. 2022 Aug;
13(1):1358-1378.
PMID: 35943142
infects various crops with aflatoxins, and leads to aspergillosis opportunistically. Though H3K36 methylation plays an important role in fungal toxin metabolism and virulence, no data about the biological function of...
10.
Deng Y, Chen X, Huang C, Song J, Feng S, Chen X, et al.
J Oncol
. 2022 Apr;
2022:3794021.
PMID: 35444699
Background: Although more pathologic stage-I lung adenocarcinoma (LUAD) was diagnosed recently, some relapsed or distantly metastasized shortly after radical resection. The study aimed to identify biomarkers predicting prognosis in the...